Poly (ethylene glycol) methyl ether 5000 (mPEG 5000)

<strong>Poly(ethylene glycol) methyl ether 5000</strong>_x000D_ <strong>Catalog number:</strong> B2010415_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 g_x000D_ <strong>Molecular Weight or Concentration:</strong> average Mn 5,000_x000D_ <strong>Supplied as:</strong> Flakes/crystals_x000D_ <strong>Appearance:</strong> White_x000D_ <strong>Applications:</strong> highly pure Poly(ethylene glycol) methyl ether (mPEG) with an average MW of 5000._x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> Methoxy poly(ethylene glycol), mPEG5000, PEG 5000, PEG5000, mPEG 5000, Polyethylene glycol monomethyl ether_x000D_ <strong>Grade:</strong> Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Peng J, Chen J, Xie F, Bao W, Xu H, Wang H, Xu Y, Du Z. Herceptin-conjugated_x000D_ paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial_x000D_ treatment of HER2-positive breast cancer. Biomaterials. 2019 Nov;222:119420._x000D_ _x000D_ 2: Gill KK, Nazzal S, Kaddoumi A. Paclitaxel loaded PEG(5000)-DSPE micelles as_x000D_ pulmonary delivery platform: formulation characterization, tissue distribution,_x000D_ plasma pharmacokinetics, and toxicological evaluation. Eur J Pharm Biopharm._x000D_ 2011 Oct;79(2):276-84._x000D_ _x000D_ 3: Liu M, Chu Y, Liu H, Su Y, Zhang Q, Jiao J, Liu M, Ding J, Liu M, Hu Y, Dai_x000D_ Y, Zhang R, Liu X, Deng Y, Song Y. Accelerated Blood Clearance of Nanoemulsions_x000D_ Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The_x000D_ Effect of PEG-Lipid Linkages and PEG Molecular Weights. Mol Pharm. 2020 Apr_x000D_ 6;17(4):1059-1070._x000D_ _x000D_ 4: Saleem M, Martin H, Coates P. Prolactin Biology and Laboratory Measurement:_x000D_ An Update on Physiology and Current Analytical Issues. Clin Biochem Rev. 2018_x000D_ Feb;39(1):3-16._x000D_ _x000D_ 5: Tehrani SF, Bernard-Patrzynski F, Puscas I, Leclair G, Hildgen P, Roullin VG._x000D_ Length of surface PEG modulates nanocarrier transcytosis across brain vascular_x000D_ endothelial cells. Nanomedicine. 2019 Feb;16:185-194._x000D_ _x000D_ 6: Jiao J, Jiao X, Wang C, Wei L, Wang G, Deng Y, Song Y. The Contribution of_x000D_ PEG Molecular Weights in PEGylated Emulsions to the Various Phases in the_x000D_ Accelerated Blood Clearance (ABC) Phenomenon in Rats. AAPS PharmSciTech. 2020_x000D_ Nov 2;21(8):300._x000D_ _x000D_ 7: Ke S, Wright JC, Kwon GS. Avidin-biotin-PEG-CPA complexes as potential EPR-_x000D_ directed therapeutic protein carriers: preparation and characterization._x000D_ Bioconjug Chem. 2007 Sep-Oct;18(5):1644-50._x000D_ _x000D_ 8: Schiavon O, Pasut G, Moro S, Orsolini P, Guiotto A, Veronese FM. PEG-Ara-C_x000D_ conjugates for controlled release. Eur J Med Chem. 2004 Feb;39(2):123-33._x000D_ _x000D_ 9: Hoffman RM, Tan Y, Li S, Han Q, Yagi S, Takakura T, Takimoto A, Inagaki K,_x000D_ Kudou D. Development of Recombinant Methioninase for Cancer Treatment. Methods_x000D_ Mol Biol. 2019;1866:107-131._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/32751591/">10: Kim MH, Kim DH, Nguyen DT, Lee HS, Kang NW, Baek MJ, An J, Yoo SY, Mun YH,_x000D_ Lee W, Kim KT, Cho CW, Lee JY, Kim DD. Preparation and Evaluation of Eudragit_x000D_ L100-PEG Proliponiosomes for Enhanced Oral Delivery of Celecoxib. Pharmaceutics._x000D_ 2020 Jul 30;12(8):718. </a>_x000D_ _x000D_ <strong>Products Related to Poly(ethylene glycol) methyl ether 5000 </strong> <a href="https://moleculardepot.com/product-category/Chemicals/">: Chemicals</a>